Dose-volume histogram parameters and patient-reported EPIC-Bowel domain in prostate cancer proton therapy
Gabriella F. Bulman, Ronik S. Bhangoo, Todd A. DeWees, Molly M. Petersen, Cameron S. Thorpe, William W. Wong, Jean Claude M. Rwigema, Thomas B. Daniels, Sameer R. Keole, Steven E. Schild, Carlos E. Vargas
Radiat Oncol J. 2021;39(2):122-128. Published online 2021 Jun 24 DOI: https://doi.org/10.3857/roj.2021.00388
Citations to this article as recorded by 
Application of Photon-Derived Worst-Case Robustness Criteria to Proton Therapy Planning
Krishmita Siwakoti, Allison P. Dalton, Jared A. Maas, Andrew M. McDonald, Samuel R. Marcrom, Rex A. Cardan, Joseph Harms, John B. Fiveash, Adam J. Kole
International Journal of Particle Therapy.2025; 15: 100740. CrossRef
Long-Term Patient-Reported Bowel and Urinary Quality of Life in Patients Treated with Intensity-Modulated Radiotherapy Versus Intensity-Modulated Proton Therapy for Localized Prostate Cancer
Kimberly R. Gergelis, Miao Bai, Jiasen Ma, David M. Routman, Bradley J. Stish, Brian J. Davis, Thomas M. Pisansky, Thomas J. Whitaker, Richard Choo
Current Oncology.2025; 32(4): 212. CrossRef